Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call
Title:
Event Date:
Time:
Participant Numbers: +1-800-343-5172 (
The conference ID “CIBUS” or 24287 will be required for entry
Event Link: https://investor.cibus.com/events
For interested individuals unable to join the conference call, a dial-in replay of the call will be available through
A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.
About Cibus
Cibus is a leader in developing traits (characteristics) that address critical productivity, yield and sustainability challenges. Cibus’ proprietary high-throughput gene-editing technologies drive its long-term focus on productivity traits for farmers for the major global row crops. Cibus is not a seed company. It is a technology company that uses its gene editing technologies to develop plant traits at a fraction of the time and cost of conventional breeding and to license them to customers in exchange for royalties, leveraging its strong partnerships across the seed industry as a whole.
Cibus Contacts:
Investor Relations
jeff.sonnek@icrinc.com
Media Relations
colin@bioscribe.com
203-918-4347
Source: Cibus US LLC